Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Maraviroc in HIV/HCV Coinfection and Liver Fibrosis
2009-010912-14Phase 3Active
- Sponsor
- ASST Spedali Civili di Brescia
- Start
- Mar 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of maraviroc in human immunodeficiency virus infection (HIV), hepatitis C virus infection and hepatic fibrosis (2 arms), sponsored by ASST Spedali Civili di Brescia. Primary endpoints: Change in liver fibrosis stage at week 48 and Change in liver fibrosis stage at week 96. Started Mar 2009; status: active.
02
Drugs
maraviroc
03
Conditions
human immunodeficiency virus infection (HIV)hepatitis C virus infectionhepatic fibrosis
Beyond the preview
Go deeper on 2009-010912-14.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-010912-14.